ABBV: AbbVie Inc

ABBV新闻

• Investing 13:13 AbbVie’s upadacitinib shows promising results for alopecia areata
• Seeking Alpha 19:23 Top 10 Income Funds From Eaton Vance
• Zacks 14:00 Pfizer (PFE) Expected to Beat Earnings Estimates: Should You Buy?
• Investing 12:05 AbbVie seeks FDA approval for new CLL combination therapy
• Zacks 15:16 Pre-Q2 Earnings: Is AbbVie Stock a Portfolio Must-Have?
• Benzinga 14:58 Why Is ATAI Life Sciences Stock Trading Lower On Monday? - ATAI Life Sciences (NASDAQ:ATAI)
• Zacks 14:28 Will These 5 Pharma/Biotech Bigwigs Surpass Q2 Earnings Forecasts?
• The Motley Fool 14:00 2 Top Dividend Stocks to Buy Right Now and Hold Forever
• Investing 11:55 H.C. Wainwright raises LENZ Therapeutics stock price target to $48 ahead of FDA decision
• Seeking Alpha 11:30 Built To Last: My 16-Stock Dividend Pyramid Portfolio
• TipRanks 09:36 Most Anticipated Earnings this Week – Week of July 28, 2025 - TipRanks.com
• TipRanks 08:44 The Week That Was, The Week Ahead: Macro & Markets, July 27, 2025 - TipRanks.com
• Seeking Alpha 17:20 Fidelity Equity-Income Fund Q2 2025 Commentary (Mutual Fund:FEIKX)
• The Motley Fool 08:50 The Smartest Dividend Stocks to Buy With $350 Right Now
• Seeking Alpha 01:00 Fidelity Strategic Dividend & Income Fund Q2 2025 Commentary (Mutual Fund:FSDIX)
• Investing 13:01 Goldman Sachs starts Gubra at “neutral,” cites balanced risk and limited upside
• Zacks 14:00 AbbVie (ABBV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
• Zacks 13:23 J&J Innovative Medicine Unit Shines Again in Q2: Will This Continue?
• The Motley Fool 12:45 The 3 Things That Matter for AbbVie Now
• Benzinga 12:44 Uber, Western Union, Live Nation Entertainment And A Health Care Stock On CNBC's 'Final Trades' - Live Nation Entertainment (NYSE:LYV), AbbVie (NYSE:ABBV)
• Seeking Alpha 22:32 69 July Aristocrats: Hormel Is Still The One Hot Dog
• Seeking Alpha 22:11 A Major Market Rotation Is Likely Coming
• Seeking Alpha 18:42 QDEF: Dividend ETF With Little To Show (NYSEARCA:QDEF)
• Investing 13:57 Analysis-Five years after COVID, pharma shares languish in US policy limbo